Vimarsana
Biggest News Aggregation in the World

Fusion Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fusion Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fusion Pharmaceutical Today - Breaking & Trending Today

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By William Blair - Vimarsana News

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By William Blair

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Equities research analysts at William Blair lifted their Q1 2024 EPS estimates for shares of Fusion Pharmaceuticals in a research report issued to clients and investors on Thursday, March 21st. William Blair analyst A. Hsieh now forecasts that the company will post earnings per share of ($0.39) […]

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By Wedbush - Vimarsana News

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By Wedbush

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Investment analysts at Wedbush decreased their Q1 2024 EPS estimates for Fusion Pharmaceuticals in a research note issued to investors on Wednesday, March 20th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.34) per share for the quarter, down from their prior estimate of […]

31 European Countries That Offer Citizenship by Descent - Vimarsana News

31 European Countries That Offer Citizenship by Descent

In this article, we will take a look at 31 European Countries That Offer Citizenship by Descent.

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) to Post Q1 2024 Earnings of ($0.32) Per Share, Leerink Partnrs Forecasts - Vimarsana News

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) to Post Q1 2024 Earnings of ($0.32) Per Share, Leerink Partnrs Forecasts

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for Fusion Pharmaceuticals in a note issued to investors on Monday, January 29th. Leerink Partnrs analyst F. Khurshid expects that the company will post earnings per share of ($0.32) for the quarter. The consensus […]

Source: wkrb13.com
Critical Analysis: MeiraGTx (NASDAQ:MGTX) & Fusion Pharmaceuticals (NASDAQ:FUSN) - Vimarsana News

Critical Analysis: MeiraGTx (NASDAQ:MGTX) & Fusion Pharmaceuticals (NASDAQ:FUSN)

MeiraGTx (NASDAQ:MGTX – Get Free Report) and Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership. Analyst Ratings This is a breakdown of recent […]